Russell Investments Group, Ltd. - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$376,823
-40.8%
108,595
-20.6%
0.00%0.0%
Q2 2023$636,127
-1.5%
136,802
-2.2%
0.00%0.0%
Q1 2023$646,009
-26.6%
139,829
+28.3%
0.00%
-50.0%
Q4 2022$880,419
+45.8%
108,963
-0.3%
0.00%
+100.0%
Q3 2022$604,000
-10.9%
109,255
-16.3%
0.00%0.0%
Q2 2022$678,000
+65.4%
130,464
+160.0%
0.00%0.0%
Q1 2022$410,000
+58.9%
50,176
+188.9%
0.00%
Q4 2021$258,000
-21.3%
17,3690.0%0.00%
-100.0%
Q3 2021$328,000
+1.9%
17,3690.0%0.00%0.0%
Q2 2021$322,000
-74.5%
17,369
-68.7%
0.00%
-50.0%
Q1 2021$1,263,000
+13.8%
55,534
+8.4%
0.00%0.0%
Q4 2020$1,110,000
+299.3%
51,225
+83.7%
0.00%
+100.0%
Q3 2020$278,000
+231.0%
27,886
+155.2%
0.00%
Q2 2020$84,000
-25.7%
10,925
-2.6%
0.00%
Q1 2020$113,000
-4.2%
11,216
+3.3%
0.00%
Q4 2019$118,00010,8570.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders